Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • RESEARCH HIGHLIGHT

A test for Alzheimer’s-disease stage predicts dementia risk

Levels of a host of molecules in the cerebrospinal fluid reliably assess development of the disease.
A coloured scan (blue and yellow) of a human brain showing physical signs of Alzheimer's disease.

The brain (artificially coloured) of a person with Alzheimer’s disease. Credit: Living Art Enterprises/Science Photo Library

A computer algorithm that analyses molecules in the fluid surrounding the brain and spinal cord can track the progression of Alzheimer’s disease1.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 628, 11 (2024)

doi: https://doi.org/10.1038/d41586-024-00860-9

References

  1. Salvadó, G. et al. Nature Aging https://doi.org/10.1038/s43587-024-00599-y (2024).

    Article  Google Scholar 

Download references

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links